Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results90% success

Data Visualizations

Phase Distribution

5Total
P 2 (2)
P 3 (1)
P 4 (2)

Trial Status

Completed9
Unknown1
Terminated1
Withdrawn1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05499052CompletedPrimary

Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice

NCT01510054WithdrawnPrimary

Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA

NCT00988260Phase 2CompletedPrimary

Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

NCT03697031TerminatedPrimary

Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®

NCT03564509Phase 2CompletedPrimary

A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.

NCT03393780CompletedPrimary

Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures

NCT00725491Phase 3CompletedPrimary

A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

NCT04503707CompletedPrimary

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

NCT04122729Unknown

N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS

NCT03051087Phase 4CompletedPrimary

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

NCT03366025CompletedPrimary

Progesterone Variation on the Final Day of Oocyte Maturation.

NCT01339299Phase 4CompletedPrimary

Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)

Showing all 12 trials

Research Network

Activity Timeline